Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety, tolerability, and efficacy of eteplirsen in Duchenne Muscular Dystrophy participants who completed a prior study has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• eteplirsen (eteplirsen)

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: TERMINATED | Results posted: 2023-08-18